Ahead of adcomm, FDA discusses Seikagaku’s mixed trial results for its lumbar disc herniation injection

Japan-based Seikagaku will face an FDA advisory committee on Friday, with the agency raising concerns ahead of the meeting regarding the efficacy of its condoliase …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Many polio survivors face lifelong late effects

Polio survivors facing the little-known late effects of the disease are being overlooked, writes Neena Bhandari.

October 23, 2024

Cannes Lions entries for pharma, health & wellness awards signal return to business as usual

Pharma advertising award submissions for the annual Cannes Lions creativity festival rose by almost 20% this year, signaling a return to business as usual after

June 17, 2023

SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations – Biotech Investments

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Personnel SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations 30.04.2024 / 17:00 CET/CEST

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.